November 26-27, 2015, China Biological Products Annual Conference 2015, in the same way, the 15th National Biological Products Symposium was in held in Shenzhen, China. Several well-known experts and scholars made a series of exciting reports in the field of biomedical science and technology and reported the latest progress in the relevant areas. The topics in this conference were “major new drug discovery”, “the generic drug market and regulations”, “the current progress of enterprise projects and international standards”, and so on.

Experts Reporting in the Conference

The theme of this annual conference is the development and progress of cells and laboratory animals for vaccine, blood products, recombinant protein drugs, gene therapy drugs, recombinant antibody drugs, tumor cell immune cell therapy and macromolecular targeted drug development, production and assay. The conference set up the main venue and three sub-sites of preventive biological products, therapeutic biological products, stem cells and gene therapy. At the seminar, dozens of well-known experts in biomedicine analyzed the latest research results and trends in biomedical fields at home and abroad, especially vaccines, antibodies and stem cells, and combined with domestic biomedical research and development policies and international development trends to jointly explore biomedical R&D in China. The status quo and difficulties, and put forward valuable opinions, the participating enterprises have benefited a lot.

Experts in the Question & Answer

As a leading distributor of life science products in China, Beijing Zhongyuan Co., Ltd. is an authorized distributor of many internationally renowned biotechnology companies and institutions in China. Beijing Zhongyuan Company attended the exhibition with many products and services. The products include ATCC strains for research, biological standards, Addgene plasmids, molecular biology products, cell biology products, immunological products, conventional biochemical reagents, life science instrument consumables, etc.; also have pharmaceutical equipment for the pilot production and the original Excipients such as BD medium, various filtration products, purified products, etc.; the chief scientist of the Central Plains led the R&D and process development team to participate in the conference, and introduced the process development of our team in recent years to many companies such as vaccines and antibodies. The future development direction has been affirmed by the company, and it is hoped that more exchanges will be learned and cooperation will be made in the future.